Anna Waller
Overview
Explore the profile of Anna Waller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
1804
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Waller A, Harmon K, Neuroth L, Johnson L
N C Med J
. 2024 Sep;
84(4):269-270.
PMID: 39302307
No abstract available.
2.
Lautenschlager T, Geary S, Waller A
N C Med J
. 2024 Sep;
84(4):242-247.
PMID: 39302306
The COVID-19 pandemic has had far-reaching impacts on the health and well-being of North Carolinians, including injury and violence. Firearm purchases surged and, as the pandemic evolved, North Carolinians experienced...
3.
Metzger V, Cannon D, Yang J, Mathias S, Bologa C, Waller A, et al.
PeerJ
. 2024 Jul;
12:e17470.
PMID: 38948230
TIN-X (Target Importance and Novelty eXplorer) is an interactive visualization tool for illuminating associations between diseases and potential drug targets and is publicly available at newdrugtargets.org. TIN-X uses natural language...
4.
Vidovic D, Waller A, Holmes J, Sklar L, Schurer S
Drug Discov Today
. 2024 Mar;
29(5):103953.
PMID: 38508231
The Illuminating the Druggable Genome (IDG) consortium generated reagents, biological model systems, data, informatic databases, and computational tools. The Resource Dissemination and Outreach Center (RDOC) played a central administrative role,...
5.
Oprea T, Bologa C, Holmes J, Mathias S, Metzger V, Waller A, et al.
Drug Discov Today
. 2024 Jan;
29(3):103882.
PMID: 38218214
The Knowledge Management Center (KMC) for the Illuminating the Druggable Genome (IDG) project aims to aggregate, update, and articulate protein-centric data knowledge for the entire human proteome, with emphasis on...
6.
Radhakrishnan L, Carey K, Pell D, Ising A, Brathwaite D, Waller A, et al.
MMWR Morb Mortal Wkly Rep
. 2023 Sep;
72(38):1032-1040.
PMID: 37733637
Mental and behavioral health conditions among school-aged children, including substance use disorders and overall emotional well-being, are a public health concern in the United States. Timely data on seasonal patterns...
7.
Ising A, Waller A, Frerichs L
J Public Health Manag Pract
. 2023 Mar;
29(3):369-376.
PMID: 36867507
Context: Local health departments (LHDs) need timely county-level and subcounty-level data to monitor health-related trends, identify health disparities, and inform areas of highest need for interventions as part of their...
8.
Yang J, Grissa D, Lambert C, Bologa C, Mathias S, Waller A, et al.
Bioinformatics
. 2021 Jun;
37(21):3865-3873.
PMID: 34086846
Motivation: Genome-wide association studies can reveal important genotype-phenotype associations; however, data quality and interpretability issues must be addressed. For drug discovery scientists seeking to prioritize targets based on the available...
9.
Sheils T, Mathias S, Kelleher K, Siramshetty V, Nguyen D, Bologa C, et al.
Nucleic Acids Res
. 2020 Nov;
49(D1):D1334-D1346.
PMID: 33156327
In 2014, the National Institutes of Health (NIH) initiated the Illuminating the Druggable Genome (IDG) program to identify and improve our understanding of poorly characterized proteins that can potentially be...
10.
Sheils T, Mathias S, Siramshetty V, Bocci G, Bologa C, Yang J, et al.
Curr Protoc Bioinformatics
. 2020 Jan;
69(1):e92.
PMID: 31898878
Pharos is an integrated web-based informatics platform for the analysis of data aggregated by the Illuminating the Druggable Genome (IDG) Knowledge Management Center, an NIH Common Fund initiative. The current...